Physiologic Dysfunction of Dorsolateral Prefrontal Cortex in Schizophrenia: II. Role of Neuroleptic Treatment, Attention, and Mental Effort

Archives of General Psychiatry

Volumn 43, Issue 2, 1986, Pages 126-135

  Berman, Karen Faith ^a   Zec, Ronald F ^a   Weinberger, Daniel R ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; NEUROLEPTIC AGENT; RADIOISOTOPE; XENON 133;

ATTENTION; BRAIN BLOOD FLOW; BRAIN CORTEX; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; COGNITION; DRUG EFFICACY; DRUG MECHANISM; DRUG THERAPY; EXERCISE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PERIPHERAL VASCULAR SYSTEM; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; SCHIZOPHRENIA; TASK PERFORMANCE; THERAPY;

ADULT; ANTIPSYCHOTIC AGENTS; AROUSAL; ATTENTION; CEREBROVASCULAR CIRCULATION; CHRONIC DISEASE; COGNITION; FEMALE; FRONTAL LOBE; HUMAN; MALE; NEUROPSYCHOLOGICAL TESTS; PSYCHOMOTOR PERFORMANCE; REGIONAL BLOOD FLOW; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0022579449     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.1986.01800020032005     Document Type: Article

References (71)

1. Levin S: Frontal lobe dysfunctions in schizophrenia: II. Impairments of psychological and brain functions. J Psychiatr Res 1984;18:57-72.
2. Parfitt DN: The neurology of schizophrenia. J Ment Sci 1956;102:671-718.
3. Seidman LJ: Schizophrenia and brain dysfunction: An integration of recent neurodiagnostic findings. Psychol Bull 1983;94:195-238.
4. Weinberger DR: CAT scan findings in schizophrenia: Speculation on the meaning of it all. J Psychiatr Res 1984;18:477-490.
5. Weinberger DR: Clinical neuropathological correlations in schizophrenia: Theoretical implications, in Alpert M (ed): Controversies in Schizophrenia. New York, Guilford Press, in press.
6. Hecaen H, Albert ML: Disorders of mental functioning related to frontal lobe pathology, in Benson DF, Blumer D (eds): Psychiatric Aspects of Neurologic Disease. New York, Grune & Stratton, 1975, pp 137-149.
7. Quitkin F, Rifkin A, Klein D: Neurologic soft signs in schizophrenia and character disorders. Arch Gen Psychiatry 1976;33:845-853.
8. Malmo HP: On frontal lobe functions: Psychiatric patient controls. Cortex 1974;10:231-237.
9. Kolb B, Whishaw IQ: Performance of schizophrenic patients on tests sensitive to left or right frontal temporal parietal function in neurological patients. J Nerv Ment Dis 1983;171:435-443.
10. Taylor MA, Abrams R: Cognitive impairment in schizophrenia. Am J Psychiatry 1984;141:196-201.
11. Lawson WB, Waldman IN, Weinberger DR: Schizophrenic dementia: Results of neuropsychological testing and clinical correlates. J Clin Psychiatry, in press.
12. Mialet JP, Pichot P: Eye tracking patterns in schizophrenia. Arch Gen Psychiatry 1981;38:183-186.
13. Buchsbaum MS, Ingvar DH, Kessler R, Waters RN, Cappelliti J, van Kammen DP, King AC, Johnson JL, Manning RG, Flynn RN, Mann LS, Bunney WE, Sokoloff L: Cerebral glucography with positron tomography. Arch Gen Psychiatry 1982;39:251-259.
14. Farchas T, Wolf AP, Jeager J, Brodie JD, Christman DR, Fowler JS: Regional brain glucose metabolism in chronic schizophrenia. Arch Gen Psychiatry 1984;41:293-300.
15. Buchsbaum MS, DeLisi LE, Holcomb HH, Cappelletti J, King AC, Johnson J, Hazlett E, Dowling-Zimmerman S, Post RM, Morihisa J, Carpenter W, Cohen R, Pickar D, Weinberger DR, Margolin R, Kessler RM: Anteroposterior gradients in cerebral glucose use in schizophrenia and affective disorders. Arch Gen Psychiatry 1984;41:1159-1166.
16. Morihisa JM, McAnulty GB: Structure and function: Brain electrical activity mapping and computed tomography in schizophrenia. Biol Psychiatry 1985;20:3-19.
17. Buchsbaum MS, Cappelletti J, Coppola R, Regal F, King AC, van Kammen DP: New methods to determine CNS effects of antigeriatric compounds: EEG topography and glucose use. Drug Dev Res 1982;2:489-496.
18. Franzen G, Ingvar DH: Abnormal distribution of cerebral activity in chronic schizophrenia. J Psychiatr Res 1975;12:199-214.
19. Franzen G, Ingvar DH: Absence of activation in frontal structures during psychological testing of chronic schizophrenics. J Neurol Neurosurg Psychiatry 1975;38:1027-1032.
20. Ingvar DH, Franzen G: Distribution of cerebral activity in chronic schizophrenia. Lancet 1974;2:1484-1486.
21. Ingvar DH, Franzen G: Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia. Acta Psychiatr Scand 1974;50:425-462.
22. Ariel RN, Golden CJ, Berg RA, Quaife MA, Dirksen JW, Forsell T, Wilson J, Graber B: Regional cerebral blood flow in schizophrenia with the 133-xenon inhalation method. Arch Gen Psychiatry 1983;40:258-263.
23. Shepphard G, Gruzelier J, Manchanda R, Hirsch SR, Wise R, Frackowiak R, Jones T: 15O positron emission tomography scanning in predominantly never treated acute schizophrenia patients. Lancet 1983;2:1448-1452.
24. Widen L, Blomgrist G, DePaulis T, Ehrin E, Eriksson L, Farde L, Greitz T, Hedstrom CG, Ingvar DH, Litton JE, Nilsson JLG, Ogren SO, Sedvall G, Stone-Elander S, Wiesel F-A, and Wik G: Studies of schizophrenia with positron CT. J Clin Neuropharmacol 1984;7(suppl 1):538-539.
25. Gur RE, Skolnick BE, Gur RC, Caroff S, Rieger W, Obrist WD, Younkin D, Reivich M: Brain functions in psychiatric disorder: I. Regional cerebral blood flow in medicated schizophrenics. Arch Gen Psychiatry 1983;40:1250-1254.
26. Mathew RJ, Duncan GC, Weinman ML, Barr DL: Regional cerebral blood flow in schizophrenia. Arch Gen Psychiatry 1982;39:1121-1124.
27. Weinberger DR, Berman KF, Zec RF: Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia: I. Regional cerebral blood flow evidence. Arch Gen Psychiatry 1986;43:114-124.
28. Fuster J: The Prefrontal Cortex. New York, Raven Press, 1980.
29. Stuss DT, Benson DF: Frontal lobe lesions and behavior, in Kertesz A (ed): Localization in Neuropsychology. New York, Academic Press Inc, 1983, pp 429-454.
30. Stuss DT, Benson DF, Kaplan EF, Weir WS, Malva CD: Leucotomized and nonleucotomized schizophrenics: Comparison of tests of attention. Biol Psychiatry 1981;16:1085-1100.
31. Stuss DT, Benson DF, Kaplan EF, Weir WS, Naeser MA, Lieberman I, Ferrill D: The involvement of orbitofrontal cerebrum in cognitive tasks. Neuropsychologia 1983;21:235-248.
32. Benson DF, Stuss DT, Naeser MA, Weir WS, Kaplan EF, Levine HL: The long-term effects of prefrontal leukotomy. Arch Neurol 1981;38:165-169.
33. Milner B: Effects of different brain lesions on card sorting. Arch Neurol 1963;9:100-110.
34. Milner B: Some effects of frontal lobectomy in man, in Warren JM, Akert K (eds): The Frontal Granular Cortex and Behavior. New York, McGraw-Hill Book Co, 1963, pp 313-334.
35. Milner B: Interhemispheric differences in the localization of psychological processes in man. Br Med Bull 1971;27:272-277.
36. Milner B, Petrides M: Behavioral effects of frontal lobe lesions in man. Trends Neurosci 1984;7:403-407.
37. Mirsky AF, Orren MM: Attention, in Miller LH, Sandman CA, Kastin AJ (eds): Neuropeptide Influences on the Brain and Behavior. New York, Raven Press, 1977, pp 233-267.
38. Mirsky AF, Primac DW, Ajmone-Marsan C, Rosvold HE, Stevens JR: A comparison of the psychological test performance of patients with focal and nonfocal epilepsy. Exp Neurol 1960;2:75-89.
39. Mirsky AF, Orzack MH: Final Report on Psychosurgery pilot study, in Psychosurgery: the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. US Government Printing Office, 1976, Appendix II, pp 1-168.
40. Rosvold HE, Mirsky AF, Sarason I, Bransome ED Jr, Beck LH: A continuous performance test of brain damage. J Consult Clin Psychol 1956:20:343-350.
41. Garmezy N: Attentional processes in adult schizophrenia and in children at risk. J Psychiatr Res 1978;14:3-34.
42. Wohlberg GW, Kornetsky C: Sustained attention in remitted schizophrenics. Arch Gen Psychiatry 1973;28:533-537.
43. Orzack MH, Kornetsky C: Attention dysfunction in chronic schizophrenia. Arch Gen Psychiatry 1966;14:323-326.
44. Orzack MH, Kornetsky C: Environmental and familial predictors of attention behavior in chronic schizophrenics. J Psychiatr Res 1971;9:21-29.
45. Kornetsky C, Orzack MH: Psychological and behavioral correlates of attention dysfunction in schizophrenic patients. J Psychiatr Res 1978;14:69-79.
46. Chapman LJ: Recent advances in the study of schizophrenic cognition. Schizophr Bull 1979;5:568-580.
47. Spitzer RL, Endicott J, Robins E: Research Diagnostic Criteria, ed 3. New York, Biometrics Research Division, New York State Psychiatric Institute, 1978.
48. American Psychiatric Association Committee on Nomenclature and Statistics: Diagnostic and Statistical Manual of Mental Disorders, ed 3. Washington, DC, American Psychiatric Association, 1980.
49. Mathew RJ, Barr DL, Weinman ML: Caffeine and cerebral blood flow. Br J Psychiatry 1983;143:604-608.
50. Skinhoj E, Olesen J, Paulson O: Influence of smoking and nicotine on cerebral blood flow and metabolic rate of oxygen in man. J Appl Physiol 1973;35:820-822.
51. Obrist WD, Thompson HK, Wang HS, Wilkinson WE: Regional cerebral blood flow estimated by 133 xenon inhalation. Stroke 1975;6:245-256.
52. Deshmukh VD, Meyer JS: Noninvasive Measurement of Cerebral Blood Flow. Englewood Cliffs, NJ, Prentice-Hall Inc, 1978.
53. Risberg J: Regional cerebral blood flow measurements by 133 Xeinhalation: Methodology and applications in neuropsychology and psychiatry. Brain Lang 1980;9:9-34.
54. Berman KF, Weinberger DR, Morihisa JM, Zee RF: Xenon133 inhalation regional cerebral blood flow: Application to psychiatric research, in Morihisa JM (ed): Brain Imaging in Psychiatry. Washington, DC, American Psychiatric Association, 1984, pp 4-64.
55. Obrist WD, Wilkinson WE: The non-invasive Xe-133 method: Evaluation of CBF indices, in Bes A, Geraud G (eds): Cerebral Circulation. Amsterdam, Elsevier North Holland Inc, 1980, pp 119-124.
56. Wood F: Theoretical, methodological, and statistical implications of the inhalation rCBF technique for the study of brain-behavior relationships. Brain Lang 1980;9:1-8.
57. Mazziota JC, Phelps ME, Carson RE, Kuhl DE: Tomographic mapping of human cerebral metabolism: Sensory deprivation. Ann Neurol 1982;12:435-444.
58. Duara R, Barker W, Apicella A, Chang J, Siegel C, Finn R, Gilson A: Resting cerebral glucose metabolism: Intraindividual versus interindividual variability in young and elderly subjects, abstracted. Neurology 1985;35(suppl 1):138.
59. Duara R, Sevush S, Gross-Glenn K, Chang J, Barker W, Apicella A, Gilson A, Finn R: Intraindividual reliability of cerebral glucose metabolism in the resting state and during psychological activation, abstracted. Neurology 1985;35(suppl 1):138.
60. Risberg J, Maximilian V, Prohovnik I: Changes of cortical activity patterns during habituation to a reasoning test: A study of the 133 Xe inhalation technique for measurement of regional cerebral blood flow. Neuropsychologia 1977;15:793-798.
61. McHenry LL, Merory J, Bass E, Stump DA, Williams R, Witcofski R, Howard G, Toole JF: Xenon 133 inhalation method for regional cerebral blood flow measurements: Normal values and test-retest results. Stroke 1978;9:396-399.
62. Coppola R, Buchsbaum MS, Rigal F: Computer generation of surface distribution maps of measures of brain activity. Comput Biol Med 1982;12:191-199.
63. Bannon MJ, Roth RH: Pharmacology of mesocortical dopamine neurons. Pharmacol Rev 1983;35:53-68.
64. Bannon MJ, Reinhard JF Jr, Bunney EB, Roth RH: Unique response to antipsychotic drugs is due to the absence of terminal autoreceptors in mesocortical dopamine neurons. Nature 1982;296:444-446.
65. Garmezy N: The psychology and psychopathology of attention. Schizophr Bull 1977;3:360-369.
66. Mirsky AF: Neuropsychological bases of schizophrenia. Annu Rev Psychol 1969:20:321-348.
67. Kornetsky C, Mirsky AF: On certain psychopharmacological and physiological differences between schizophrenics and normal persons. Psychopharmacologia 1966;8:309-318.
68. Mirsky AF: Attention: A neuropsychological perspective, in Chall JS, Mirsky AF (eds): Education and the Brain. Chicago, University of Chicago Press, 1978, pp 33-60.
69. Weinberger DR, Berman KF: Huntington's disease and subcortical dementia: rCBF evidence. Neurology 1985;35(suppl 1):109.
70. Shelton R, Ingraham L, Weinberger DR: Cerebral structural pathology in schizophrenia: A new cohort. Presented as a scientific exhibit at the 40 annual convention and scientific program of the Society of Biological Psychiatry, Dallas, May 17, 1985.
71. Weinberger DR, Kleinman JE: Observations on the brain in schizophrenia, in Hales RE, Frances AJ (eds): Psychiatry Update 1986, American Psychiatric Association Annual Review. Washington, DC, American Psychiatric Association, in press.